Aetna Inc (AET) Shares Sold by Renaissance Group LLC

Renaissance Group LLC decreased its holdings in Aetna Inc (NYSE:AET) by 9.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 222,472 shares of the company’s stock after selling 22,107 shares during the period. Aetna makes up 1.4% of Renaissance Group LLC’s portfolio, making the stock its 4th largest holding. Renaissance Group LLC’s holdings in Aetna were worth $40,132,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Bedel Financial Consulting Inc. purchased a new stake in shares of Aetna during the 4th quarter valued at about $271,000. California Public Employees Retirement System increased its position in shares of Aetna by 3.2% during the 4th quarter. California Public Employees Retirement System now owns 939,426 shares of the company’s stock valued at $169,463,000 after purchasing an additional 29,237 shares during the last quarter. Putnam FL Investment Management Co. increased its position in shares of Aetna by 218.9% during the 4th quarter. Putnam FL Investment Management Co. now owns 58,472 shares of the company’s stock valued at $10,548,000 after purchasing an additional 40,139 shares during the last quarter. Price Capital Management Inc. purchased a new stake in shares of Aetna during the 4th quarter valued at about $1,602,000. Finally, ING Groep NV increased its position in shares of Aetna by 165.6% during the 4th quarter. ING Groep NV now owns 31,006 shares of the company’s stock valued at $5,593,000 after purchasing an additional 19,332 shares during the last quarter. 87.41% of the stock is owned by institutional investors and hedge funds.

Aetna Inc (AET) opened at $180.00 on Friday. Aetna Inc has a 52 week low of $121.01 and a 52 week high of $194.40. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $59,310.93, a P/E ratio of 30.96, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60.

Aetna (NYSE:AET) last posted its earnings results on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.07. The firm had revenue of $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The company’s quarterly revenue was down 6.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.08 EPS. equities analysts anticipate that Aetna Inc will post 10.99 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were given a dividend of $0.50 per share. The ex-dividend date was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.11%. Aetna’s dividend payout ratio is currently 34.78%.

Several equities research analysts have recently commented on the stock. Citigroup lowered shares of Aetna from a “buy” rating to a “neutral” rating and upped their price target for the company from $187.89 to $212.00 in a research report on Wednesday, January 31st. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Piper Jaffray Companies reaffirmed a “buy” rating and set a $212.00 price target on shares of Aetna in a research report on Tuesday, January 30th. Credit Suisse Group upped their price target on shares of Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a research report on Wednesday, January 31st. Finally, Cowen reiterated a “buy” rating and set a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Ten analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Aetna presently has a consensus rating of “Buy” and a consensus target price of $185.94.

WARNING: “Aetna Inc (AET) Shares Sold by Renaissance Group LLC” was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.com-unik.info/2018/02/09/aetna-inc-aet-shares-sold-by-renaissance-group-llc.html.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit